The pathogenesis, diagnosis and treatment of Raynaud phenomenon.
about
The primary vascular dysregulation syndrome: implications for eye diseasesVascular Remodelling and Mesenchymal Transition in Systemic SclerosisSex differences in Sjögren's syndrome: a comprehensive review of immune mechanismsState of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?Raynaud's Phenomenon: A Brief Review of the Underlying MechanismsIn silico modeling of human α2C-adrenoreceptor interaction with filamin-2Hand-arm vibration syndrome: What family physicians should knowProtective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury.Conversion to Paradoxical Finding on Technetium-99m-labeled RBC Scintigraphy after Treatment for Secondary Raynaud's PhenomenonA non-invasive technique for the evaluation of peripheral circulatory functions in female subjects with Raynaud's phenomenonBotulinum Toxin Off-Label Use in Dermatology: A Review.Prevalence of Raynaud phenomenon and nailfold capillaroscopic abnormalities in Fabry disease: a cross-sectional studyReduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon.Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.[Nailfold capillaroscopy].Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.Update on macrophages and innate immunity in sclerodermaThe long-term effects of occupational exposure to vinyl chloride monomer on microcirculation: a cross-sectional study 15 years after retirement.Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Severe Primary Raynaud's Disease Treated with Rituximab.Raynaud's of the tongue following chemoradiation for squamous cell carcinoma of the oropharynx.The association between vibration and vascular injury in rheumatic diseases: a review of the literature.A vascular mechanistic approach to understanding Raynaud phenomenon.Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.Emerging drugs and therapeutics for systemic sclerosis.Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception.Therapeutic implications from the pathogenesis of Raynaud's phenomenon.Herbal Prescription, DSGOST, Prevents Cold-Induced RhoA Activation and Endothelin-1 Production in Endothelial Cells.Handy Hints About Raynaud's Phenomenon in Children: A Critical Review.Relationship of age and body mass index to skin temperature and skin perfusion in primary Raynaud's phenomenon.Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.Treatment of digital ulcers in systemic sclerosis: Case series study of thirteen patients and discussion on outcome.Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010.Mechanistic insight into the norepinephrine-induced fibrosis in systemic sclerosis.Evaluation of nail fold capillaroscopy findings in patients with primary biliary cirrhosis.Maladie des vibrations: Ce que tout médecin de famille devrait savoir.Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.Chronic inflammation predicts long-term mortality in patients with Raynaud's phenomenon.
P2860
Q21198720-D7ED7858-B775-4A49-910E-4D232AAB4A7FQ26749091-33716C5E-02FD-4495-983F-2542D71FAF56Q26780324-37A11ABC-F52F-4366-BD76-310182CD80CEQ27009491-1740F88E-5723-4513-A791-A35AF9EC7788Q28067805-BD59A2DD-7773-496F-A3DB-7E0260D19886Q28392073-B79422C2-E100-4438-B77D-749780AA1F59Q30235284-13CBD847-0964-4684-B30A-1AC9692B154FQ33562360-C990FD68-D050-4377-B51B-61899ABBCF29Q33669895-A92CCE9B-4C1E-4130-86B0-20674FADE9E9Q33773749-72DA7B17-0DF7-4DB2-B5AA-D2EC468FE311Q33781874-521A7EFD-6AB3-460A-B308-388EC47F2D2BQ34669916-8DDBE564-CC8B-4EA9-8AE1-4ED26FF76AA2Q34698456-A00DCF48-DAAA-486E-AD0C-9ADAF1DA4E09Q35066987-B9B2EC9E-F7BE-407F-9552-2066F658E9DFQ35128462-C649D604-555F-4B4A-845F-DCF87084F068Q35668003-790BF7CC-EDB5-4DFA-A83D-0ACF3452C465Q36091433-3BA44729-FE72-4CFC-8775-62E532A4B00CQ36607887-22884B48-0908-4E51-B0B2-64F08BD0A218Q36939181-C9EBD2E7-6014-4F84-84C2-6DE1FA0B50A2Q37030669-58B242E1-B576-4AA6-B004-AD97E84C80CDQ37224668-D1B14A3B-B4AC-49F0-8599-2629648E68E0Q37250044-C423FA30-9685-4026-ADC9-11B924CF0974Q37701776-E140D9AA-34B8-4267-AFAF-62D48C929972Q38238935-51109922-CC3E-40BC-BC8A-B917579A017BQ38299133-07E2BBD4-7804-4E2E-8F37-A2A2D0306A55Q38809851-7D3CD39A-44B1-4BE7-B5A0-4215B465F229Q38998611-DD263211-24DE-45B1-83D3-3E79F7EC0875Q39031432-704555BD-5112-4CDA-8FAC-6ED169B99AA9Q39090456-61E3527C-D3D5-49D0-A6EB-CC6E401E1D26Q39197971-E25821B5-9ADF-47B8-84C6-C0736C227039Q39317533-163061AD-6E0F-4C8A-88E1-9EA5C3278C7DQ40230164-0E985AEA-3818-4861-B34C-45C30CC073F5Q40296383-52C4087E-1012-4334-A7D2-1D559D52CBB4Q40487885-E521E423-0827-4D6F-BA0F-73E35D59605DQ40813743-009B86E5-A0CB-4A10-B644-BC7BE8B96DD2Q41139937-1D97262B-997D-438A-AC4E-B90607800A27Q42263045-4A33A9E6-F1F5-475A-9F81-0A9E08F802F1Q46984775-EE3ACDAD-7209-4465-BBDA-8DD56A4915D2Q47400242-9247607D-9478-44CE-96E5-CA04A3F01EDAQ47606503-CF26994B-C988-442E-A4F9-DE06771C02B4
P2860
The pathogenesis, diagnosis and treatment of Raynaud phenomenon.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The pathogenesis, diagnosis and treatment of Raynaud phenomenon.
@en
type
label
The pathogenesis, diagnosis and treatment of Raynaud phenomenon.
@en
prefLabel
The pathogenesis, diagnosis and treatment of Raynaud phenomenon.
@en
P2860
P356
P1476
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
@en
P2093
Ariane L Herrick
P2860
P2888
P304
P356
10.1038/NRRHEUM.2012.96
P407
P577
2012-07-10T00:00:00Z
P6179
1051870725